These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 16181843

  • 1. Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model.
    Kent MS, Korn P, Port JL, Lee PC, Altorki NK, Korst RJ.
    Ann Thorac Surg; 2005 Oct; 80(4):1215-22; discussion 1222-3. PubMed ID: 16181843
    [Abstract] [Full Text] [Related]

  • 2. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
    van Loon J, Grutters JP, Wanders R, Boersma L, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Simons J, Brans B, Snoep G, Hochstenbag M, Lambin P, De Ruysscher D.
    Eur J Cancer; 2010 Jan; 46(1):110-9. PubMed ID: 19944595
    [Abstract] [Full Text] [Related]

  • 3. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance.
    Lou F, Huang J, Sima CS, Dycoco J, Rusch V, Bach PB.
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):75-81; discussion 81-2. PubMed ID: 23127371
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA.
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [Abstract] [Full Text] [Related]

  • 5. Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer.
    Korst RJ, Kansler AL, Port JL, Lee PC, Altorki NK.
    Ann Thorac Surg; 2006 Sep; 82(3):1009-15; discussion 1015. PubMed ID: 16928526
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer.
    Schreyögg J, Weller J, Stargardt T, Herrmann K, Bluemel C, Dechow T, Glatting G, Krause BJ, Mottaghy F, Reske SN, Buck AK.
    J Nucl Med; 2010 Nov; 51(11):1668-75. PubMed ID: 21051648
    [Abstract] [Full Text] [Related]

  • 7. Surveillance computed tomography after complete resection for non-small cell lung cancer: results and costs.
    Korst RJ, Gold HT, Kent MS, Port JL, Lee PC, Altorki NK.
    J Thorac Cardiovasc Surg; 2005 Mar; 129(3):652-60. PubMed ID: 15746751
    [Abstract] [Full Text] [Related]

  • 8. Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis.
    Das P, Ng AK, Earle CC, Mauch PM, Kuntz KM.
    Ann Oncol; 2006 May; 17(5):785-93. PubMed ID: 16500905
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of positron emission tomography for the management of potentially operable non-small cell lung cancer in Quebec.
    Nguyen VH, Peloquin S, Lacasse Y.
    Can Respir J; 2005 May; 12(1):19-25. PubMed ID: 15776130
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease.
    Guadagnolo BA, Punglia RS, Kuntz KM, Mauch PM, Ng AK.
    J Clin Oncol; 2006 Sep 01; 24(25):4116-22. PubMed ID: 16943528
    [Abstract] [Full Text] [Related]

  • 11. Decision-tree sensitivity analysis for cost-effectiveness of chest 2-fluoro-2-D-[(18)F]fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small cell lung carcinoma) in Japan.
    Kosuda S, Ichihara K, Watanabe M, Kobayashi H, Kusano S.
    Chest; 2000 Feb 01; 117(2):346-53. PubMed ID: 10669673
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of whole-body CT screening.
    Beinfeld MT, Wittenberg E, Gazelle GS.
    Radiology; 2005 Feb 01; 234(2):415-22. PubMed ID: 15670999
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.
    Puri V, Crabtree TD, Kymes S, Gregory M, Bell J, Bradley JD, Robinson C, Patterson GA, Kreisel D, Krupnick AS, Meyers BF.
    J Thorac Cardiovasc Surg; 2012 Feb 01; 143(2):428-36. PubMed ID: 22169443
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy.
    Eloubeidi MA, Tamhane A, Chen VK, Cerfolio RJ.
    Ann Thorac Surg; 2005 Oct 01; 80(4):1231-9. PubMed ID: 16181845
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.